COVID-19 & CancerFree NCI to distribute IL-6 inhibitor for cancer patients with COVID-19 lung inflammation April 10, 2020Vol.46 No.15By Matthew Bin Han Ong
COVID-19 & CancerFreeGuest Editorial Chernobyl doctor’s view of COVID-19: Trump threatens 267 years of progress in biomedical research April 10, 2020Vol.46 No.15By Robert Peter Gale
COVID-19 & CancerFreeGuest Editorial NCTN group chairs: Cancer trials take backseat to clinical care amid COVID-19 pandemic April 10, 2020Vol.46 No.15By Charles D. Blanke, Douglas S. Hawkins, Monica M. Bertagnolli, Peter J. O'Dwyer, Mitchell D. Schnall, Walter J. Curran, Norman Wolmark, Robert S. Mannel and Janet Dancey
Conversation with The Cancer LetterCOVID-19 & CancerFree COVID-19 lesson from Spain: Like the U.S., we failed to take this seriously before it came to us—we have to learn April 09, 2020Vol.46 No.15By Matthew Bin Han Ong
Conversation with The Cancer LetterCOVID-19 & CancerFree Libutti: Rutgers studies COVID-19 while bracing for its surge April 06, 2020Vol.46 No.15By Paul Goldberg
Drugs & TargetsFree EMA grants positive opinion to Adcetris combination in lymphoma indication April 03, 2020Vol.46 No.14
Clinical RoundupFree Keytruda significantly improves PFS as first-line treatment in colorectal cancer indication April 03, 2020Vol.46 No.14
Clinical RoundupFree Phase III cancer vaccine trial meets primary endpoint April 03, 2020Vol.46 No.14
